DeepMed Research

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib
Drug: Melphalan
Procedure: Autologous Stem Cell Transplant
Drug: Fludarabine
Procedure: Allogeneic Stem Cell Transplant

First Posted Date: 2009-07-29

Last Posted Date: 2019-09-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 124

Registration Number: NCT00948922

Locations: 🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

Phase 1

Terminated

Conditions: Brain Metastases

Interventions: Drug: Bendamustine

First Posted Date: 2009-04-09

Last Posted Date: 2012-12-18

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 12

Registration Number: NCT00879073

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation

Phase 2

Terminated

Conditions: Lung Cancer

Interventions: Drug: Dasatinib

First Posted Date: 2009-03-09

Last Posted Date: 2014-01-15

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 7

Registration Number: NCT00858403

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Phase 1

Completed

Conditions: Leukemia

Interventions: Drug: lenalidomide
Biological: bystander vaccine

First Posted Date: 2009-02-11

Last Posted Date: 2019-12-11

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 22

Registration Number: NCT00840931

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

Phase 2

Terminated

Conditions: Pancreatic Neoplasms

Interventions: Drug: GTX (gemcitabine, docetaxel and capecitabine)
Radiation: stereotactic body radiation therapy

First Posted Date: 2009-02-02

Last Posted Date: 2017-10-09

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 2

Registration Number: NCT00833859

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

Phase 1

Completed

Conditions: Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions: Drug: Idarubicin
Drug: Cytarabine
Drug: Lenalidomide (Revlimid®)

First Posted Date: 2009-01-29

Last Posted Date: 2020-12-22

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 51

Registration Number: NCT00831766

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸
Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States

The Human Papillomavirus (HPV) Transmission Pilot Study

Completed

Conditions: Human Papillomavirus Infection

First Posted Date: 2009-01-15

Last Posted Date: 2015-01-28

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 137

Registration Number: NCT00823511

Locations: 🇺🇸
Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

Completed

Conditions: Cancer
Cancer Screening Patients
Patient Volunteers

Interventions: Behavioral: First Questionnaire
Behavioral: Health History
Behavioral: Second Questionnaire

First Posted Date: 2009-01-14

Last Posted Date: 2013-11-25

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 17

Registration Number: NCT00822822

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Liposuction for Arm Lymphedema Following Breast Cancer Surgery

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: Liposuction
Other: Quality of Life Questionnaires

First Posted Date: 2009-01-06

Last Posted Date: 2021-06-24

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 7

Registration Number: NCT00816985

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

Not Applicable

Completed

Conditions: Nicotine Dependence

Interventions: Behavioral: Tobacco
Other: Alcoholic Beverage
Other: Placebo

First Posted Date: 2009-01-01

Last Posted Date: 2019-09-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 244

Registration Number: NCT00816231

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy